Published in Oncotarget on February 28, 2017
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med (2009) 5.54
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest (2008) 5.26
The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol (2003) 3.53
WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol (2008) 3.46
Wnt signaling in cancer. Cold Spring Harb Perspect Biol (2012) 2.75
Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity (2007) 2.71
Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity (2011) 2.64
Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med (2008) 2.52
The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. Nat Immunol (2001) 2.27
T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat Immunol (2009) 1.99
Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol (2004) 1.89
Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity (2014) 1.87
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest (2009) 1.73
Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol (2010) 1.64
Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin (2008) 1.60
Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog (2011) 1.44
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun (2013) 1.34
Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg (2006) 1.31
The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol (2008) 1.25
Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol (2002) 1.25
Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res (2007) 1.25
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics (2014) 1.22
Beta-catenin does not regulate memory T cell phenotype. Nat Med (2010) 1.13
Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity (2013) 1.13
Noncanonical Wnt signaling promotes apoptosis in thymocyte development. J Exp Med (2007) 1.10
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis. J Clin Invest (2014) 1.07
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis (2011) 1.05
The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity (2008) 1.04
Overexpression of Wnt-2 in colorectal cancers. Neoplasma (2009) 1.03
Interleukin-17: a promoter in colorectal cancer progression. Clin Dev Immunol (2013) 1.00
Cutting edge: β-catenin is dispensable for T cell effector differentiation, memory formation, and recall responses. J Immunol (2011) 1.00
Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation. J Immunol (2010) 0.99
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. Cancer Microenviron (2011) 0.99
β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med (2014) 0.96
Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. J Exp Clin Cancer Res (2014) 0.93
Stabilisation of β-catenin downstream of T cell receptor signalling. PLoS One (2010) 0.93
Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. J Immunol Res (2014) 0.92
Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells. Anticancer Res (2002) 0.89
Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis. Cell Death Dis (2015) 0.83
Deficiency of interferon-gamma or its receptor promotes colorectal cancer development. J Interferon Cytokine Res (2014) 0.82
IL-17 cuts to the chase in colon cancer. Immunity (2014) 0.81
IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells. Cancer Lett (2013) 0.80
The Wnt inhibitor secreted Frizzled-Related Protein 1 (sFRP1) promotes human Th17 differentiation. Eur J Immunol (2012) 0.80
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res (2015) 0.78
Anti-proliferative effect of interferon-gamma is enhanced by iron chelation in colon cancer cell lines in vitro. Hepatogastroenterology (2008) 0.77
Blockade of Wnt/β-Catenin Pathway Aggravated Silica-Induced Lung Inflammation through Tregs Regulation on Th Immune Responses. Mediators Inflamm (2016) 0.77